Publications by authors named "I Cortes-Puch"

Article Synopsis
  • Chronic pain affects about 20% of the U.S. population, leading to the development of EC5026, a new non-opioid, non-NSAID pain relief drug that inhibits soluble epoxide hydrolase (sEH).
  • Two phase I clinical trials demonstrated that EC5026 is well tolerated in healthy volunteers, showing no serious side effects or significant changes in vital signs or lab results.
  • Pharmacokinetic analysis indicated that EC5026 has a prolonged half-life (around 59 hours), making it suitable for once-daily dosing, and results support further clinical trials for its effectiveness in treating pain.
View Article and Find Full Text PDF

Background: Bleeding is a known complication during bronchoscopy, with increased incidence in patients undergoing a more invasive procedure. Phenylephrine is a potent vasoconstrictor that can control airway bleeding when applied topically and has been used as an alternative to epinephrine. The clinical effects of endobronchial phenylephrine on systemic vasoconstriction have not been clearly evaluated.

View Article and Find Full Text PDF

Background: Early mobility interventions in intensive care units (ICUs) are safe and improve outcomes in subsets of critically ill adults. However, implementation varies, and the optimal mobility dose remains unclear.

Objective: To test for associations between daily dose of out-of-bed mobility and patient outcomes in different ICUs.

View Article and Find Full Text PDF

Background: The ratio of oxygen saturation index (ROX index; or S /F /breathing frequency) has been shown to predict risk of intubation after high-flow nasal cannula (HFNC) support among adults with acute hypoxemic respiratory failure primarily due to pneumonia. However, its predictive value for other subtypes of respiratory failure is unknown. This study investigated whether the ROX index predicts liberation from HFNC or noninvasive ventilation (NIV), intubation with mechanical ventilation, or death in adults admitted for respiratory failure due to an exacerbation of COPD.

View Article and Find Full Text PDF